Skip to main content
Clinical Trials/NCT03622879
NCT03622879
Recruiting
N/A

Effect of Mirror Therapy with Cutaneous Electrical Sensory Stimulation on Lower Limb Motor Functions in People with Stroke: a Single-blinded Randomized Controlled Trial

The Hong Kong Polytechnic University1 site in 1 country100 target enrollmentJuly 2, 2018
ConditionsStroke

Overview

Phase
N/A
Intervention
Not specified
Conditions
Stroke
Sponsor
The Hong Kong Polytechnic University
Enrollment
100
Locations
1
Primary Endpoint
The Change of Fugl-Meyer Assessment of Lower Extremity (FMA-LE)
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

This study aims to evaluate the effectiveness of concurrent mirror therapy (MT) and transcutaneous electrical nerve stimulation (TENS) in augmenting the efficacy of the lower limb task-oriented training in people with stroke. It is hypothesize that MT combined with TENS would be superior to sham-mirror therapy with TENS, or MT with placebo-TENS, or control training only in improving lower limb motor functions and walking ability in people with stroke when combined with the lower limb task-oriented training.

Detailed Description

The application of transcutaneous electrical nerve stimulation (TENS) over a paretic lower limb could augment the effects of task-oriented exercise therapy on lower limb motor function in people with stroke, possibly through increased excitability of sensorimotor cortex. In mirror therapy (MT), the intact limb performs motor tasks while its mirror reflection is superimposed over the covered paretic limb, creating a visual illusion of enhanced function over the paretic limb. The visual input during MT could substitute for reduced proprioceptive inputs and increase spatial attention of the paretic limb, which could improve motor function of the paretic limb, possibly through increased cortical activity in the lesioned hemisphere and mirror neurone system. The next question concerns whether MT could be combined with TENS and whether their synergetic effects could maximise the motor output of paretic limbs in people with stroke.

Registry
clinicaltrials.gov
Start Date
July 2, 2018
End Date
June 1, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Shamay Ng

Associate Professor

The Hong Kong Polytechnic University

Eligibility Criteria

Inclusion Criteria

  • have had a single stroke with ischemic brain injury or intracerebral haemorrhage diagnosed by magnetic resonance imaging or computed tomography within the previous 6 to 36 months;
  • have at least 5 degrees of active ankle dorsiflexion in the antigravity position;
  • are able to walk 10 m independently with or without a walking aid;
  • are able to score 6 or higher out of 10 on the abbreviated mental test;
  • have no unilateral neglect, hemianopia or apraxia;
  • have no skin allergy (e.g. redness or itchiness to the electrical stimulation pads) to electrical stimulation or electrodes; and
  • are able to follow instructions and give informed consent.

Exclusion Criteria

  • have any additional medical, cardiovascular or orthopaedic condition that would hinder proper treatment or assessment;
  • have visual deficits that may hinder them from benefiting from the mirror visual feedback;
  • have receptive dysphasia; or
  • are involved in drug studies or other clinical trials.

Outcomes

Primary Outcomes

The Change of Fugl-Meyer Assessment of Lower Extremity (FMA-LE)

Time Frame: Baseline (0 week), Mid-intervention (4 weeks), Post-intervention (8 weeks), 3-month follow-up (20 weeks)

FMA-LE is used to evaluate the lower extremity motor control, including reflexes, voluntary control of isolated movement and coordination. The scale score ranging from 0 to 34, with 17 items and ordinal scoring from 0 to 2. A higher score indicates a better lower extremity motor control. The assessment will be conducted at baseline, mid-intervention (4 weeks), post-intervention (8 weeks) and 3-month follow-up (20 weeks).

Secondary Outcomes

  • The Change of Paretic ankle dorsiflexor strength(Baseline (0 week), Mid-intervention (4 weeks), Post-intervention (8 weeks), 3-month follow-up (20 weeks))
  • The Change of Paretic ankle plantarflexor strength(Baseline (0 week), Mid-intervention (4 weeks), Post-intervention (8 weeks), 3-month follow-up (20 weeks))
  • The Change of 10-m walk test(Baseline (0 week), Mid-intervention (4 weeks), Post-intervention (8 weeks), 3-month follow-up (20 weeks))
  • The Change of Timed 'Up and Go' test(Baseline (0 week), Mid-intervention (4 weeks), Post-intervention (8 weeks), 3-month follow-up (20 weeks))
  • The Change of Lower-extremity motor co-ordination test(Baseline (0 week), Mid-intervention (4 weeks), Post-intervention (8 weeks), 3-month follow-up (20 weeks))
  • The Change of Cantonese version of Community Integration Measures (CIM-C)(Baseline (0 week), Mid-intervention (4 weeks), Post-intervention (8 weeks), 3-month follow-up (20 weeks))

Study Sites (1)

Loading locations...

Similar Trials